Blau Farmaceutica SA (BLAU3) Stock Statistics & Valuation Metrics

Blau Farmaceutica SA has a market cap or net worth of $2.10B. The enterprise value is $2.29B.

Market Cap

$2.10B

Enterprise Value

$2.29B

Blau Farmaceutica SA has 233,212,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

233,212,130

Owned by Insiders

―

Owned by Institutions

0.36%

Blau Farmaceutica SA’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 7.99%.

Return on Equity (ROE)

0.13

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

7.99%

Return on Capital Employed (ROCE)

0.12

Revenue Per Employee

895.99K

Profits Per Employee

155.24K

Employee Count

1,900

Asset Turnover

0.47

Inventory Turnover

1.51

The current PE Ratio of Blau Farmaceutica SA is 8.13. Blau Farmaceutica SA’s PEG ratio is -0.27.

PE Ratio

8.13

PS Ratio

1.17

PB Ratio

0.88

Price to FCF

16.06

Price to Operating Cash Flow

5.35

PEG Ratio

-0.27

In the last 12 months, Blau Farmaceutica SA had revenue of 1.70B and earned 294.95M in profits. Earnings per share was 0.98.

Revenue

1.70B

Gross Profit

652.52M

Operating Income

329.75M

Pretax Income

388.47M

Net Income

294.95M

EBITDA

394.08M

Earnings Per Share (EPS)

0.98

In the last 12 months, operating cash flow was 385.45M and capital expenditures -255.75M, giving a free cash flow of 129.70M billion.

Operating Cash Flow

385.45M

Free Cash Flow

129.70M

Free Cash Flow per Share

0.57

Blau Farmaceutica SA pays an annual dividend of ―, resulting in a dividend yield of 8.28%

Dividend Per Share

―

Dividend Yield

8.28%

Payout Ratio

N/A

Free Cash Flow Yield

6.23%

Earnings Yield

11.33%

Beta

1.16

52-Week Price Change

-9.73%

50-Day Moving Average

10.60

200-Day Moving Average

10.14

Relative Strength Index (RSI)

29.74

Average Volume (3m)

312.04K

Blau Farmaceutica SA upcoming earnings date is Nov 10, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 11, 2026

Next Earnings Date

Nov 10, 2026

Ex-Dividend Date

―

Blau Farmaceutica SA as a current ratio of 2.47, with Debt / Equity ratio of 26.37%

Current Ratio

2.47

Quick Ratio

1.57

Debt to Market Cap

0.17

Net Debt to EBITDA

1.40

Interest Coverage Ratio

4.40

In the past 12 months, Blau Farmaceutica SA has paid 91.70M in taxes.

Income Tax

91.70M

Effective Tax Rate

0.24

Blau Farmaceutica SA EV to EBITDA ratio is 5.53, with an EV/FCF ratio of 22.28.

EV to Sales

1.62

EV to EBITDA

5.53

EV to Free Cash Flow

22.28

EV to Operating Cash Flow

7.50

Blau Farmaceutica SA has $884.87M in cash and marketable securities with $853.09M in debt, giving a net cash position of $31.78M billion.

Cash & Marketable Securities

$884.87M

Total Debt

$853.09M

Net Cash

$31.78M

Net Cash Per Share

$0.14

Tangible Book Value Per Share

$7.03

Gross margin is 39.76%, with operating margin of 19.15%, and net profit margin of 13.09%.

Gross Margin

39.76%

Operating Margin

19.15%

Pretax Margin

16.81%

Net Profit Margin

13.09%

EBITDA Margin

29.24%

EBIT Margin

25.11%

The average price target for Blau Farmaceutica SA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

1.06%

EPS Growth Forecast

-19.82%